P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN®-multiantigen vaccine: high responder rate and considerable breadth of immunological response

Overton, T; Schmidt, D; Hain, J; Virgin, G; Steigerwald, R; Dirmeier, U; Jordan, E; Meyer, T; Young, P; Ludvigsen, A; Nichols, R; Chaplin, P

doi:10.1186/1742-4690-6-S3-P411

Retrovirology

Article metrics
Last updated: Sat, 20 Apr 2024 12:37:23 Z

P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN^®-multiantigen vaccine: high responder rate and considerable breadth of immunological response

Access & Citations

1129

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1742-4690

Contact us

Submission enquiries: journalsubmissions@springernature.com